Connection

James Chalmers to Pulmonary Disease, Chronic Obstructive

Back to Details
This is a "connection" page, showing publications James Chalmers has written about Pulmonary Disease, Chronic Obstructive.
James Chalmers
Connection Strength
2.356
Pulmonary Disease, Chronic Obstructive
  1. The overlap between bronchiectasis and chronic airway diseases: state of the art and future directions. Eur Respir J. 2018 09; 52(3).
    View in: PubMed
    Score: 0.215
  2. Assessing the healthcare resource use associated with inappropriate prescribing of inhaled corticosteroids for people with chronic obstructive pulmonary disease (COPD) in GOLD groups A or B: an observational study using the Clinical Practice Research Datalink (CPRD). Respir Res. 2018 04 11; 19(1):63.
    View in: PubMed
    Score: 0.208
  3. POINT: Should an Attempt Be Made to Withdraw Inhaled Corticosteroids in All Patients With Stable GOLD 3 (30% = FEV1 < 50% Predicted) COPD? Yes. Chest. 2018 04; 153(4):778-782.
    View in: PubMed
    Score: 0.206
  4. Rebuttal From Dr Chalmers. Chest. 2018 04; 153(4):785-786.
    View in: PubMed
    Score: 0.206
  5. Genetic mannose binding lectin deficiency is associated with airway microbiota diversity and reduced exacerbation frequency in COPD. Thorax. 2018 06; 73(6):510-518.
    View in: PubMed
    Score: 0.202
  6. Determinants of initial inhaled corticosteroid use in patients with GOLD A/B COPD: a retrospective study of UK general practice. NPJ Prim Care Respir Med. 2017 Jun 29; 27(1):43.
    View in: PubMed
    Score: 0.197
  7. Bronchiectasis and COPD Overlap: A Case of Mistaken Identity? Chest. 2017 06; 151(6):1204-1206.
    View in: PubMed
    Score: 0.196
  8. Neutrophil extracellular traps are associated with disease severity and microbiota diversity in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2018 01; 141(1):117-127.
    View in: PubMed
    Score: 0.196
  9. Management of chronic airway diseases: What can we learn from real-life data? COPD. 2017 03 15; 14(sup1):S1-S2.
    View in: PubMed
    Score: 0.193
  10. Bronchiectasis Rheumatoid Overlap Syndrome Is an Independent Risk Factor for Mortality in Patients With Bronchiectasis: A Multicenter Cohort Study. Chest. 2017 06; 151(6):1247-1254.
    View in: PubMed
    Score: 0.191
  11. Budesonide and risk of pneumonia. Lancet. 2009 Dec 19; 374(9707):2050.
    View in: PubMed
    Score: 0.117
  12. The effect of changes to GOLD severity stage on long term morbidity and mortality in COPD. Respir Res. 2018 Dec 12; 19(1):249.
    View in: PubMed
    Score: 0.055
  13. 10 years since TORCH: shining a new light on the risks of inhaled corticosteroids in COPD. Eur Respir J. 2017 09; 50(3).
    View in: PubMed
    Score: 0.050
  14. New therapies for the prevention and treatment of exacerbations of bronchiectasis. Curr Opin Pulm Med. 2017 05; 23(3):218-224.
    View in: PubMed
    Score: 0.049
  15. Raising awareness of bronchiectasis in primary care: overview of diagnosis and management strategies in adults. NPJ Prim Care Respir Med. 2017 03 13; 27(1):18.
    View in: PubMed
    Score: 0.048
  16. Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: a multinational point prevalence study of hospitalised patients. Eur Respir J. 2018 08; 52(2).
    View in: PubMed
    Score: 0.013
  17. The microbiome in respiratory medicine: current challenges and future perspectives. Eur Respir J. 2017 04; 49(4).
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.